Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids
Abstract
Long COVID (LC) represents a failure of healthy resolution mechanisms for inflammation after SARS-CoV-2 infection. Dietary essential polyunsaturated fatty acids (PUFAs) and their downstream metabolites can orchestrate inflammation resolution, suggesting these pathways may be altered in LC. In this study, plasma samples from two independent participant cohorts totaling 106 participants (designated by chart review as LC or Recovered) were collected longitudinally in the 12 months following SARS-CoV-2 infection and analyzed by mass spectrometry for targeted PUFA metabolites. In the acute phase of SARS-CoV-2 infection, upregulation of PUFA metabolites downstream of 12-lipoxygenase was associated with later development of LC. In the months following infection, LC participants displayed uncoupling of PUFA-related lipid metabolism and altered lipoxygenase-driven metabolism over time compared to recovered participants. These results provide new mechanistic insights for the development of LC and suggest potential therapeutic strategies for this prevalent and debilitating disorder.
Related
- Maternal Overweight/Obesity and Polyunsaturated Fatty Acid Status During Pregnancy Are Associated with Offspring Body Composition at 8.5 Years: Findings from the PREOBE Study
- Zileuton Beyond Asthma: A Multifaceted 5-Lipoxygenase Inhibitor With Emerging Therapeutic Potential Across Inflammation, Cancer, Neuroprotection, and Fibrosis
- Blood transcriptional variation is associated with clinical and neuroimaging phenotypes in essential tremor
- Phenolic metabolites from Ceratonia siliqua L. pods: chemical characterization, soybean lipoxygenase-1 inhibition, and in vitro gallstone-dissolving capacity
- Integrative transcriptomics and metabolomics reveal Cry1-associated hepatic alterations and plasma essential fatty acids as biomarkers of residual circadian disruption post-sepsis
BibTeX
@article{moss2026long,
title = {{Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids}},
author = {M. Elizabeth Moss and Stephanie Pons and Luciana P. Tavares and Yan Tang and Galit Alter and Elizabeth Karlson and Lindsey Baden and David R. Walt and Bruce D. Levy},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117581},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)02960-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids
AU - M. Elizabeth Moss
AU - Stephanie Pons
AU - Luciana P. Tavares
AU - Yan Tang
AU - Galit Alter
AU - Elizabeth Karlson
AU - Lindsey Baden
AU - David R. Walt
AU - Bruce D. Levy
PY - 2026
DA - 2026/10/14
JO - iScience
DO - 10.1016/j.isci.2026.117581
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)02960-3
AB - Long COVID (LC) represents a failure of healthy resolution mechanisms for inflammation after SARS-CoV-2 infection. Dietary essential polyunsaturated fatty acids (PUFAs) and their downstream metabolites can orchestrate inflammation resolution, suggesting these pathways may be altered in LC. In this study, plasma samples from two independent participant cohorts totaling 106 participants (designated by chart review as LC or Recovered) were collected longitudinally in the 12 months following SARS-CoV-2 infection and analyzed by mass spectrometry for targeted PUFA metabolites. In the acute phase of SARS-CoV-2 infection, upregulation of PUFA metabolites downstream of 12-lipoxygenase was associated with later development of LC. In the months following infection, LC participants displayed uncoupling of PUFA-related lipid metabolism and altered lipoxygenase-driven metabolism over time compared to recovered participants. These results provide new mechanistic insights for the development of LC and suggest potential therapeutic strategies for this prevalent and debilitating disorder.
SN - 2589-0042
ER -